We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.01B
1-Year Est. Return 47.79%
This Fund
S&P 500
This Quarter Est. Return
+2.93%
1 Year Est. Return
+47.79%
3 Year Est. Return
+184.24%
5 Year Est. Return
+273.21%
10 Year Est. Return
+1,255.9%
AUM
$3.01B
AUM Growth
-$77.5M
Cap. Flow
-$45.6M
Cap. Flow %
-1.52%
Top 10 Hldgs %
32.99%
Holding
119
New
6
Increased
40
Reduced
57
Closed
7

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$28.4M
2
TDY icon
Teledyne Technologies
TDY
+$17.1M
3
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$14.5M
4
IQV icon
IQVIA
IQV
+$13.6M
5
R icon
Ryder
R
+$12M

Top Sells

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$25.9M
2
NOW icon
ServiceNow
NOW
+$22.6M
3
BSX icon
Boston Scientific
BSX
+$12.1M
4
MU icon
Micron Technology
MU
+$11.7M
5
WDC icon
Western Digital
WDC
+$9.36M

Sector Composition

Rank Sector Weight
1 Technology 30.15%
2 Financials 13.03%
3 Communication Services 10.89%
4 Industrials 10.55%
5 Healthcare 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VICI icon
76
VICI Properties
VICI
$29B
$15.8M 0.52%
577,037
-3,588
-0.6% -$103K
LDOS icon
77
Leidos
LDOS
$13.9B
$15.5M 0.51%
99,461
-23,509
-19% -$4.22M
BLK icon
78
Blackrock
BLK
$161B
$14.4M 0.48%
14,925
-7,423
-33% -$7.81M
R icon
79
Ryder
R
$10.4B
$12.2M 0.41%
+59,542
New +$12M
IQV icon
80
IQVIA
IQV
$34.6B
$11.9M 0.39%
+69,628
New +$13.6M
CRNX icon
81
Crinetics Pharmaceuticals
CRNX
$8.85B
$11.8M 0.39%
+324,808
New +$14.5M
PODD icon
82
Insulet
PODD
$11B
$10.9M 0.36%
51,858
-3,987
-7% -$1M
ANET icon
83
Arista Networks
ANET
$222B
$9.46M 0.31%
77,034
-9,605
-11% -$1.28M
PFGC icon
84
Performance Food Group
PFGC
$17.3B
$8.77M 0.29%
102,429
-26,660
-21% -$2.44M
VRSN icon
85
VeriSign
VRSN
$23.8B
$8.26M 0.27%
33,255
-16,791
-34% -$4M
GTLS
86
DELISTED
Chart Industries
GTLS
$7.12M 0.24%
34,450
-24,136
-41% -$5M
BSX icon
87
Boston Scientific
BSX
$64.8B
$6.61M 0.22%
105,341
-151,752
-59% -$12.1M
SPY icon
88
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$3.74M 0.12%
5,757
-167
-3% -$114K
MCD icon
89
McDonald's
MCD
$187B
$3.58M 0.12%
11,505
– –
SHW icon
90
Sherwin-Williams
SHW
$76.6B
$2.86M 0.1%
8,935
– –
ITRI icon
91
Itron
ITRI
$3.72B
$2.58M 0.09%
28,750
-38,679
-57% -$3.71M
AMGN icon
92
Amgen
AMGN
$201B
$1.58M 0.05%
4,500
-300
-6% -$107K
EXE
93
Expand Energy Corp
EXE
$21.9B
$1.49M 0.05%
13,575
– –
IBM icon
94
IBM
IBM
$194B
$1.36M 0.05%
5,630
– –
V icon
95
Visa
V
$669B
$1.36M 0.05%
4,500
– –
QSR icon
96
Restaurant Brands International
QSR
$25.1B
$1.2M 0.04%
16,250
-24
-0.1% -$1.69K
MDY icon
97
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
$1.15M 0.04%
1,871
+322
+21% +$204K
ATO icon
98
Atmos Energy
ATO
$29.7B
$934K 0.03%
5,057
– –
RSP icon
99
Invesco S&P 500 Equal Weight ETF
RSP
$95.3B
$635K 0.02%
3,311
– –
TXN icon
100
Texas Instruments
TXN
$259B
$524K 0.02%
2,700
– –
1 2 3
4
5

Similar funds

CI
Conning Inc Hartford, Connecticut $3.01B AUM 16.23% 1-Year Est. Return
BGDI
BW Gestao de Investimentos Sao Paulo, Brazil $3.01B AUM 27.43% 1-Year Est. Return
Members Trust
Members Trust Tampa, Florida $3.01B AUM 10.24% 1-Year Est. Return
ROTUOC
Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return
VVP
Venture Visionary Partners Sylvania, Ohio $3B AUM 24.41% 1-Year Est. Return
KIA
KCM Investment Advisors Greenbrae, California $3.01B AUM 21.97% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return

Braun Stacey Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Braun Stacey Associates held 119 positions worth $3.01B, down 2.5% from $3.09B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Braun Stacey Associates's Q1 2026 filing shows 6 new, 40 increased, 57 reduced and 7 closed positions. Its largest new stake was Merck: 246,022 shares worth $29.6M. The largest sale was Neurocrine Biosciences, an estimated $25.9M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Financials and Communication Services.

  • Braun Stacey Associates's largest Q1 2026 buy was Merck: 246,022 shares worth $29.6M.
  • Braun Stacey Associates added most to Ascendis Pharma A/S in Q1 2026, an estimated $2.67M increase.
  • Braun Stacey Associates's biggest Q1 2026 reduction was Boston Scientific, cutting an estimated $12.1M.
  • Braun Stacey Associates fully exited Neurocrine Biosciences in Q1 2026, selling an estimated $25.9M.
  • Braun Stacey Associates's ten largest holdings make up 33% of its $3.01B portfolio in Q1 2026.
  • Braun Stacey Associates opened 6 new positions and closed 7 in Q1 2026.
  • Braun Stacey Associates's portfolio value fell 2.5% quarter-over-quarter to $3.01B.

Based on Braun Stacey Associates's 13F filing for Q1 2026, filed 22 Apr 2026.